Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Healthcare Drug Manufacturers - Major Cannabis Cannabis
Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Canopy Growth Corp > Canopy CEO on BNN
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3100)
•••
Comment by quinlashon Mar 27, 2024 9:13am
94 Views
Post# 35955031

RE:Canopy CEO on BNN

RE:Canopy CEO on BNN
quinlash wrote: PoW Group posted a BNN interview with the CEO of Canopy. Judging by the chart they pull up I'm thinking it's pretty recent.  

The topics discussed by the Canopy CEO include market size and opportunities in regard to them having a medical division in country within Germany.

Sorry, I can't post a link at the moment but should be easy enough to find on YouTube 


Lou,

The CEO of canopy has already addressed each of your concerns in various interviews and press release issued by the company.  Go search Canopy CEO interview on YouTube

As for infrastructure in Germany, Google Canopy Medical Germany and you can literally check out the operation that is up and running there, it's been there for a number of years already

No need to thank me, but you may want to revise your bet




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities